Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise
Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise.
Medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise.
Medpace Holdings (MEDP) stock surged by double digits Thursday, helped by a big bookings beat, rebounding from a poor start to the year. The contract research organization, or CRO, put up a book-to-bill ratio of 1.13x, easily above expectations for 0.95x to 1.01x, according to Leerink Partners analyst Michael Cherny. That means Medpace received more new orders than it can…
Sinergia Empresarial continuará el seguimiento de esta información sobre medpace Notches A Big Bookings Beat, And Reverses Its First-Quarter Malaise y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.
